These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 10477542)

  • 1. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
    Grundy SM; Benjamin IJ; Burke GL; Chait A; Eckel RH; Howard BV; Mitch W; Smith SC; Sowers JR
    Circulation; 1999 Sep; 100(10):1134-46. PubMed ID: 10477542
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
    Buse JB; Ginsberg HN; Bakris GL; Clark NG; Costa F; Eckel R; Fonseca V; Gerstein HC; Grundy S; Nesto RW; Pignone MP; Plutzky J; Porte D; Redberg R; Stitzel KF; Stone NJ; ;
    Circulation; 2007 Jan; 115(1):114-26. PubMed ID: 17192512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
    Grundy SM; Pasternak R; Greenland P; Smith S; Fuster V
    Circulation; 1999 Sep; 100(13):1481-92. PubMed ID: 10500053
    [No Abstract]   [Full Text] [Related]  

  • 4. Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the american heart association nutrition committee.
    Sacks FM; Lichtenstein A; Van Horn L; Harris W; Kris-Etherton P; Winston M
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1689-92. PubMed ID: 16857959
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.
    Pignone M; Alberts MJ; Colwell JA; Cushman M; Inzucchi SE; Mukherjee D; Rosenson RS; Williams CD; Wilson PW; Kirkman MS
    Circulation; 2010 Jun; 121(24):2694-701. PubMed ID: 20508178
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
    Gilpin VL; ; ;
    J Vasc Nurs; 2010 Dec; 28(4):154-5. PubMed ID: 21074118
    [No Abstract]   [Full Text] [Related]  

  • 7. Statement on smoking and cardiovascular disease for health care professionals. American Heart Association.
    Jonas MA; Oates JA; Ockene JK; Hennekens CH
    Circulation; 1992 Nov; 86(5):1664-9. PubMed ID: 1423984
    [No Abstract]   [Full Text] [Related]  

  • 8. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Lackland DT; Elkind MS; D'Agostino R; Dhamoon MS; Goff DC; Higashida RT; McClure LA; Mitchell PH; Sacco RL; Sila CA; Smith SC; Tanne D; Tirschwell DL; Touzé E; Wechsler LR; ; ; ; ; ;
    Stroke; 2012 Jul; 43(7):1998-2027. PubMed ID: 22627990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular disease prevention in adults with type 2 diabetes mellitus according to the recent statement from the American Heart Association/American Diabetes Association].
    Avogaro A
    G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 2):5S-11. PubMed ID: 27030118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science.
    Pearson TA; Bazzarre TL; Daniels SR; Fair JM; Fortmann SP; Franklin BA; Goldstein LB; Hong Y; Mensah GA; Sallis JF; Smith S; Stone NJ; Taubert KA;
    Circulation; 2003 Feb; 107(4):645-51. PubMed ID: 12566381
    [No Abstract]   [Full Text] [Related]  

  • 11. Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee.
    Grundy SM; Balady GJ; Criqui MH; Fletcher G; Greenland P; Hiratzka LF; Houston-Miller N; Kris-Etherton P; Krumholz HM; LaRosa J; Ockene IS; Pearson TA; Reed J; Washington R; Smith SC
    Circulation; 1997 May; 95(9):2329-31. PubMed ID: 9142014
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association.
    Circulation; 1999 Sep; 100(10):1132-3. PubMed ID: 10477541
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular preparticipation screening of competitive athletes: addendum: an addendum to a statement for health professionals from the Sudden Death Committee (Council on Clinical Cardiology) and the Congenital Cardiac Defects Committee (Council on Cardiovascular Disease in the Young), American Heart Association.
    Maron BJ; Thompson PD; Puffer JC; McGrew CA; Strong WB; Douglas PS; Clark LT; Mitten MJ; Crawford MD; Atkins DL; Driscoll DJ; Epstein AE
    Circulation; 1998 Jun; 97(22):2294. PubMed ID: 9631885
    [No Abstract]   [Full Text] [Related]  

  • 14. Trans fatty acids, plasma lipid levels, and risk of developing cardiovascular disease. A statement for healthcare professionals from the American Heart Association.
    Lichtenstein AH
    Circulation; 1997 Jun; 95(11):2588-90. PubMed ID: 9184592
    [No Abstract]   [Full Text] [Related]  

  • 15. AHA examines cardiovascular problems in diabetes. American Heart Association.
    Morey SS
    Am Fam Physician; 2000 Jan; 61(2):561, 563-4, 567. PubMed ID: 10670513
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical impact of 2020 American Heart Association statement on menopause and cardiovascular disease risk.
    Iyer TK; Hirsch H
    Cleve Clin J Med; 2022 Jan; 89(1):13-17. PubMed ID: 34983797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
    Buse JB; Ginsberg HN; Bakris GL; Clark NG; Costa F; Eckel R; Fonseca V; Gerstein HC; Grundy S; Nesto RW; Pignone MP; Plutzky J; Porte D; Redberg R; Stitzel KF; Stone NJ; ;
    Diabetes Care; 2007 Jan; 30(1):162-72. PubMed ID: 17192355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public access defibrillation. A statement for healthcare professionals from the American Heart Association Task Force on Automatic External Defibrillation.
    Weisfeldt ML; Kerber RE; McGoldrick RP; Moss AJ; Nichol G; Ornato JP; Palmer DG; Riegel B; Smith SC
    Circulation; 1995 Nov; 92(9):2763. PubMed ID: 7586388
    [No Abstract]   [Full Text] [Related]  

  • 19. American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers.
    Pearson TA; Palaniappan LP; Artinian NT; Carnethon MR; Criqui MH; Daniels SR; Fonarow GC; Fortmann SP; Franklin BA; Galloway JM; Goff DC; Heath GW; Frank AT; Kris-Etherton PM; Labarthe DR; Murabito JM; Sacco RL; Sasson C; Turner MB;
    Circulation; 2013 Apr; 127(16):1730-53. PubMed ID: 23519758
    [No Abstract]   [Full Text] [Related]  

  • 20. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
    Circulation; 2009 Jan; 119(2):351-7. PubMed ID: 19095622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.